Anticoagulation Favors Thrombus Recanalization and Survival in Patients With Liver Cirrhosis and Portal Vein Thrombosis: Results of a Meta-Analysis

INTRODUCTION: Benefit and risk of anticoagulation in cirrhotic patients with portal vein thrombosis (PVT) remain controversial, especially in those with asymptomatic PVT and in non-liver transplant candidates. Furthermore, the predictors of portal vein recanalization and bleeding events after antico...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Le, Guo, Xiaozhong, Xu, Xiangbo, De Stefano, Valerio, Plessier, Aurelie, Noronha Ferreira, Carlos, Qi, Xingshun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7854392/
https://www.ncbi.nlm.nih.gov/pubmed/33155180
http://dx.doi.org/10.1007/s12325-020-01550-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7854392/
https://www.ncbi.nlm.nih.gov/pubmed/33155180
http://dx.doi.org/10.1007/s12325-020-01550-4

Ejemplares similares